MedTrace Logo

Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer

NCT02933294 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2016-10-14

No results posted yet for this study

Summary

Lung cancer is one of the most common cancers in the world. At present, surgical resection is still the standard treatment for early stage lung cancer. Triportal thoracoscopic lung resection is a routine surgically procedure for early stage lung cancer while uniportal thoracoscopic lung resection is developing rapidly in recent years. Although uniportal VATS pulmonary resection has been proven to be effective in preventing postoperative morbidities, there is still no ample evidences to demonstrate that uniportal VATS pulmonary resection is equal or superior to traditional triportal thoracoscopic pulmonary resection. The purpose of this multicenter randomized controlled trial study is to compare the uniportal VATS with traditional triportal VATS pulmonary resection in postoperative complications, long-term survival, lymph node dissection and local recurrence.

Conditions

  • Lung Neoplasms

Interventions

PROCEDURE

Triportal pulmonary resection surgery

Uniportal video-assisted thoracoscopic surgery

PROCEDURE

Uniportal pulmonary resection surgery

Triportal video-assisted thoracoscopic surgery

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Beijing Chest Hospital

    collaborator OTHER

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Juwei Mu, MD · Collaborative Innovation Center for Cancer Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-04-30
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02933294 on ClinicalTrials.gov